about
East-Mab

Jiangsu East-Mab Biomedical Technology Co., Ltd., established in 2016, is a leading national high-tech enterprise in China, dedicated to advancing the field of recombinant proteins. Our mission is to provide high-quality industrial-grade raw materials, including diagnostic proteins, GMP-grade cytokines, enzymes, and target proteins, to meet the needs of IVD and biomedical clients worldwide.

With a commitment to excellence and innovation, East-Mab has developed a robust production infrastructure. Our facilities include a large-scale GMP workshop in Nantong and a state-of-the-art product application development platform in Suzhou, China. Spanning over 10,000 square meters, our production base is equipped with cutting-edge instruments and technologies, enabling us to maintain high standards in both production and quality control.

Our company is built on a foundation of scientific expertise. More than 110 employees, most of whom possess strong biomedical backgrounds, our team includes senior experts with deep experience in therapeutic antibody drug development and biopharmaceuticals. This expertise allows us to maintain rigorous quality control processes, ensuring the stability and reliability of our products.

East-Mab has established a leading platform for the development of recombinant proteins, featuring stable production processes and a stringent quality management system. We have earned certifications for ISO9001:2015, ISO14001:2015, and ISO45001:2018, and we are in the process of obtaining ISO13485 system certification, further demonstrating our commitment to quality and safety.

In 2021, East-Mab successfully secured millions of dollars in funding from prominent investment companies in China, underscoring the confidence in our vision and capabilities. As we continue to grow, we remain dedicated to pioneering advancements in the biomedical field, providing top-tier products that drive innovation and improve lives.